175 related articles for article (PubMed ID: 21586199)
21. [Rituximab for treatment of patients with systemic autoimmune diseases].
García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
[TBL] [Abstract][Full Text] [Related]
22. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
Tektonidou MG; Skopouli FN
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
[No Abstract] [Full Text] [Related]
23. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
Bachmeyer C; Cadranel JF; Demontis R
Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
[No Abstract] [Full Text] [Related]
24. Maintaining remission in a patient with vasculitis.
Flossmann O; Jayne DR
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
[TBL] [Abstract][Full Text] [Related]
25. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis.
Hugle B; Solomon M; Harvey E; James A; Wadhwa A; Amin R; Bell-Peter A; Benseler S
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1661-4. PubMed ID: 20583109
[TBL] [Abstract][Full Text] [Related]
26. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
[TBL] [Abstract][Full Text] [Related]
27. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
[No Abstract] [Full Text] [Related]
28. [Survival and relapses assessment in patients with Wegener's granulomatosis and predominant renal involvement].
Zycińska K; Wardyn KA
Pol Arch Med Wewn; 2007 Apr; 117(4):16-24. PubMed ID: 17722471
[TBL] [Abstract][Full Text] [Related]
29. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
30. Rituximab induced remission in a patient with Wegener's granulomatosis.
Kallenbach M; Duan H; Ring T
Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
[TBL] [Abstract][Full Text] [Related]
31. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
Villa-Forte A; Clark TM; Gomes M; Carey J; Mascha E; Karafa MT; Roberson G; Langford CA; Hoffman GS
Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
[TBL] [Abstract][Full Text] [Related]
32. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
[TBL] [Abstract][Full Text] [Related]
33. Wegener's granulomatosis with a possible thyroidal involvement.
Ozdogu H; Boga C; Bolat F; Ertorer ME
J Natl Med Assoc; 2006 Jun; 98(6):956-8. PubMed ID: 16775921
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of different refractory systemic vasculitides treated with rituximab.
Rees F; Yazdani R; Lanyon P
Clin Rheumatol; 2011 Sep; 30(9):1241-5. PubMed ID: 21523362
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.
Gottenberg JE; Mahr A; Pagnoux C; Cohen P; Mouthon L; Guillevin L;
Presse Med; 2007 May; 36(5 Pt 1):771-8. PubMed ID: 17416480
[TBL] [Abstract][Full Text] [Related]
36. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
37. Rituximab for refractory Wegener's granulomatosis.
Antoniu SA
Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
[TBL] [Abstract][Full Text] [Related]
38. Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients.
Schmitt WH; Birck R; Heinzel PA; Göbel U; Choi M; Warnatz K; Peter HH; van der Woude FJ
Nephrol Dial Transplant; 2005 Jun; 20(6):1083-92. PubMed ID: 15827051
[TBL] [Abstract][Full Text] [Related]
39. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
Seo P; Specks U; Keogh KA
J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
